Natural history of Acinetobacter baumannii infection in mice.
In 2017, the WHO identified Acinetobacter baumannii as the top priority for the development of new antibiotics. Despite the need for new antibiotics, there remains a lack of well validated preclinical tools for A. baumannii. Here, we characterize and validate a mouse model for A. baumannii translati...
Main Authors: | Brian M Luna, Jun Yan, Zeferino Reyna, Eugene Moon, Travis B Nielsen, Hernan Reza, Peggy Lu, Robert Bonomo, Arnold Louie, George Drusano, Jürgen Bulitta, Rosemary She, Brad Spellberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0219824 |
Similar Items
-
Capsule carbohydrate structure determines virulence in Acinetobacter baumannii.
by: Yuli Talyansky, et al.
Published: (2021-02-01) -
Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1
by: Brian M. Luna, et al.
Published: (2017-04-01) -
Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
by: Guanpingshen Luo, et al.
Published: (2012-01-01) -
Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut Microbiome
by: Marlène Maeusli, et al.
Published: (2020-05-01) -
Acinetobacter baumannii: problemático y además multirresistente Acinetobacter baumannii: problemátic and multiresistant
by: Guillermo PradaTrujillo
Published: (2006-06-01)